Search Clinical Pathways
Pulmonary Hypertension Screening in Patients with Bronchopulmonary Dysplasia Clinical Pathway — ICU and Inpatient
Inpatient Clinical Pathway to standardize the process to screen for pulmonary hypertension in infants with Bronchopulmonary Dysplasia (BPD). BPD remains a major source of morbidity and mortality for extremely low birth weight infants.
COVID-19 Screening Clinical Pathway — Inpatient
Clinical Pathway for Inpatient Recommendations for SARS-CoV-2 Testing provides guidance for the evaluation and care of patients with suspected coronavirus (SARS-CoV-2).
Emergency Department and Inpatient Mitochondrial Clinical Pathway
This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.
Toxic Ingestion Clinical Pathway — Emergency Department, ICU and Inpatient
This clinical pathway details the steps in identifying and managing children and adolescents who ingest toxic substances. It should be used in all cases of ingestion regardless of the child’s or adolescent’s intention.
Post-N/IICU Inpatient BPD Clinical Pathway
The post – N/IICU patient with severe Bronchopulmonary Dysplasia (BPD) clinical pathway will guide transfer from N/IICU to complex care service, weaning of respiratory support, and discharge planning.
Neuromuscular Compromise and Respiratory Failure Clinical Pathway — Inpatient and PICU
This pathway is intended for use in the inpatient pulmonary service and the PICU to guide care for patients with common neurodegenerative conditions affecting respiratory status.
Suspected Substance Withdrawal in Adolescents Clinical Pathway — Inpatient
This pathway guides the care of adolescents ≥ 12 years with suspected acute withdrawal from alcohol, benzodiazepine and/or opioid.
Somatic Symptom and Related Disorders (SSRD) Clinical Pathway — Emergency Department and Inpatient
This pathway guides the diagnosis of Somatic Symptom and Related Disorders (SSRD) where the history/physical of a patient’s chief complaint does not align with known organic medical causes.
Anti-NMDA Receptor Encephalitis Clinical Pathway — Inpatient
This pathway will guide the evaluation and treatment of a pediatric patient admitted with probable anti-NMDAR encephalitis
Croup Clinical Pathway — Emergency Department and Inpatient
The croup pathway highlights the care necessary in treating children with croup in the emergency department and inpatient settings.